Search clinical trials for: Placebo for BOTOX

Total 69948 results

University of Alberta

Withdrawn

Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

Hemorrhagic Stroke | Reversible Cerebral Vasoconstriction Syndrome | Cerebral Venous Sinus Thrombosis | Headache, Migraine | Stroke (CVA) or TIA | Botulinum Toxins, Type A | Carotid Dissection Artery | Vertebral Dissection Artery

Canada
AbbVie

Withdrawn

A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique

Ventral Hernia | Abdominal Hernia

United States
Allergan

Completed

Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines

Facial Fine Lines

United States
Weill Medical College of Cornell University

Completed

Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction

Overactive Bladder

United States
Rothman Institute Orthopaedics
Sharpe-Strumia Research Foundation

Unknown

Botulinum Toxin A to Treat Flexion Contracture After Total Knee Arthroplasty

Flexion Contracture Following Total Knee Replacement

United States
University of Rochester

Completed

A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence

Urinary Incontinence

United States
AbbVie

Recruiting

A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants

Masseter Muscle Prominence

Japan
University Hospital, Bordeaux

Completed

Are Paraspinous Intramuscular Injections of Botulinum Toxin A (BoNT-A) Efficient in the Treatment of Chronic Low-back Pain (LBP)? (BoNT-A)

Chronic Low-back Pain

France
Hospices Civils de Lyon

Completed

Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea (ALS-TOX)

Amyotrophic Lateral Sclerosis | Sialorrhea

France
JHM BioPharma (Tonghua) Co. , Ltd.

Recruiting

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
University Hospital, Limoges

Withdrawn

Early Administration of Botox® in Neuropathic Pain Due to Thoracoscopy or Thoracotomy (APTODON)

Neuropathic Pain | Pain Due to Certain Specified Procedures
University Hospital, Clermont-Ferrand
Allergan

Completed

Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor (Btx-HT)

Essential Head Tremor

France
Mayo Clinic

Completed

Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects

Obesity

United States
CHU de Reims

Completed

Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight's Doses (TBIDE)

Neurogenic Vesical Hyperactivity Syndrom

France
Emory University
Allergan

Completed

Evaluation of BOTOX® With Rehabilitation Therapy for the Treatment of Wrist and Hand Spasticity in Post-Stroke Patients (Botox/Rehab)

Stroke

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections

Acute Upper Respiratory Infections

Russian Federation
Nova Scotia Health Authority
Dalhousie University

Active, not recruiting

Onabotulinum Toxin A in Direct Brow Lift

Scarring | Direct Brow Lift

Canada
Yale University

Completed

Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches

Refractory Migraine

United States
Sheba Medical Center

Unknown

Botulinum Toxin A for Treatment of Catocholamine Induced Finger Necrosis

Catocholamine Induced Finger Necrosis

Israel
li nguyen

Unknown

ASIS for Botox in Upper Limb Spasticity (ASISinULS)

Upper Limb Spasticity Unilaterally in Adults With History of Stroke | Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.

United States
Onze Lieve Vrouwe Gasthuis

Completed

Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure

Anal Fissure

Netherlands
AbbVie

Recruiting

Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor

Upper Limb Essential Tremor (UL ET)

United States, Canada
Allergan

Active, not recruiting

Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

United States, Canada
ASIS Corporation

Unknown

ASIS for Botox in Chronic Migraine (ASISinCM)

Chronic Migraine More than15 Days Per Month, and Lasting 4 Hours a Day or Longer.

United States
li nguyen

Unknown

ASIS for Botox in Cervical Dystonia (ASISinCD)

Cervical Dystonia Adults , | Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus.

United States
EnnovaBio Australia Pharmaceuticals Pty Ltd

Not yet recruiting

A First-in-Human SAD/MAD Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ENC1018 in Healthy Adult Subjects

Healthy
ZYUS Life Sciences Inc.
Novotech (Australia) Pty Limited; ZYUS Life Sciences Australia Pty Ltd

Completed

Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation (HOPE)

Healthy | Osteoarthritis

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Healthy Participants | Atopic Dermatitis Patients

China
Oslo University Hospital

Recruiting

Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis With Botulinum Toxin A (PLATOX)

Plantar Fascitis | Gastrocnemius Tightness

Norway
GlaxoSmithKline

Recruiting

BOTOX® Drug Use Investigation (Spasmodic Dysphonia)

Dysphonia

Japan
Oregon Health and Science University
Allergan

Completed

Botox Cosmetic and the Young Patient With Glabellar Furrows

Glabellar Furrows
GlaxoSmithKline

Completed

JCP Study of Investigation of Patient Background Characteristics

Spasticity, Post-Stroke
US Department of Veterans Affairs

Withdrawn

Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.

Overactive Bladder | Urinary Incontinence

United States
University of British Columbia

Withdrawn

Comparative Trial of Botox in the Management of Children With Congenital Muscular Torticollis

Torticollis

Canada
Theravance Biopharma

Completed

SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects

Healthy

United States
University of British Columbia

Completed

Efficacy of Botox in Patients With Idiopathic Clubfoot

Idiopathic Clubfoot (Talipes Equinovarus)

Canada
Weill Medical College of Cornell University
Allergan

Terminated

The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded Examination

Stroke | Muscle Spasticity

United States
Soroka University Medical Center

Terminated

The Effect of Botox Injection on Postural Stability of Cerebral Palsy (CP) Children

Cerebral Palsy

Israel
Allergan

Completed

A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Platysma Prominence

United States, Canada
University of British Columbia

Completed

A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot

Idiopathic Clubfoot (Talipes Equinovarus)

Canada
Urological Sciences Research Foundation
Allergan

Unknown

This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. (BTX0621)

Overactive Bladder

United States
Chong Kun Dang Pharmaceutical

Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Korea, Republic of
Spero Therapeutics
Simbec Research

Completed

A Study of the Safety, Tolerability, and Pharmacokinetics of SPR720 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Hanmi Pharmaceutical Company Limited

Completed

Trial to Evaluate the Efficacy and Safety of HCP1302

Hypertension | Erectile Dysfunction
Eli Lilly and Company
OPKO Health, Inc.

Completed

A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes

Diabetes Mellitus, Type 2

United States, Puerto Rico
AstraZeneca

Completed

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

Chronic Pain

Germany, Sweden, United Kingdom
Medy-Tox

Completed

The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Russian Federation
The Research Center of Southern California

Completed

Safety and Efficacy Study of Botox in the Treatment of Forward Head Posture With Associated Episodic Headache Disorder

Forward Head Posture With Associated Episodic Headache Disorder

United States
University of Pennsylvania
Society for Urodynamics and Female Urology

Completed

Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A

Bladder Pain Syndrome
Temple University
Allergan

Completed

Itch Relieving Effect of Botox: a Study in Healthy Subjects

Pruritus

3

Subscribe